US0905722072
US0905722072
Bio-Rad Laboratories, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 9.8B EUR | 7.85B EUR | 7.48B EUR | 8.18B EUR |
Enterprise Value | 9.39B EUR | 8.7B EUR | 8.35B EUR | 9.03B EUR |
Valuation Multiples | ||||
Trailing P/E | 46.41x | 35.3x | 44.3x | 11.75x |
Forward P/E | 36.92x | -- | -- | -- |
Price to Sales | 3.78x | 3.03x | 2.89x | 4.09x |
Price to Book | 1.36x | 1.09x | 1.09x | 1.1x |
EV/Revenue | 3.63x | 3.36x | 3.22x | 4.52x |
EV/EBITDA | 21.29x | 18.03x | 17.43x | 23.64x |
Price to FCF (P/FCF) | 34.6x | 22.23x | 20.94x | 29.3x |
EV/FCF | 33.15x | 24.65x | 23.37x | 32.37x |
FCF Yield | 2.89% | 4.5% | 4.78% | 3.41% |